Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2956
Gene Symbol: MSH6
MSH6
0.010 Biomarker disease BEFREE The mass recurred 2 years later, and she underwent endoscopic endonasal biopsy demonstrating an undifferentiated carcinoma of the sella with MSH2 and MSH6 loss. 31491579 2019
Entrez Id: 1153
Gene Symbol: CIRBP
CIRBP
0.010 AlteredExpression disease BEFREE More importantly, TNM classification displayed that the low expression of Cirbp was more frequently observed in T3-T4, N2-N3, M1 and III-IV NPC biopsies, and undifferentiated carcinoma (UDC) than T1-T2, N0-N1, M0 and I-II tumors, and differentiated nonkeratinizing carcinoma (DNKC), suggesting that Cirbp loss is a key molecular event in advanced cases of NPC. 31413636 2019
Entrez Id: 912
Gene Symbol: CD1D
CD1D
0.010 Biomarker disease BEFREE In addition, histologically similar tumors to anaplastic carcinoma like sarcoma and malignant melanoma revealed distinct CD1d staining patterns. 31560833 2019
Entrez Id: 1902
Gene Symbol: LPAR1
LPAR1
0.010 AlteredExpression disease BEFREE The expression of ATX was highest in MC, while the LPA1 expression was higher in PDC and AC, and the expression of LPA2 and LPA3 was highest in PTC (p < 0.001). 31455351 2019
Entrez Id: 57492
Gene Symbol: ARID1B
ARID1B
0.010 GeneticVariation disease BEFREE Ten of the remaining 17 undifferentiated carcinomas showed the following alterations: 5 tumors (15%) showed loss of ARID1A only with intact ARID1B, BRG1, and INI1 expression, 4 tumors (12%) showed mutated patterns of p53 staining with intact SWI/SNF protein expression, and 1 tumor (3%) harbored a POLE exonuclease domain mutation (P286R). 28863077 2018
Entrez Id: 8289
Gene Symbol: ARID1A
ARID1A
0.010 GeneticVariation disease BEFREE Ten of the remaining 17 undifferentiated carcinomas showed the following alterations: 5 tumors (15%) showed loss of ARID1A only with intact ARID1B, BRG1, and INI1 expression, 4 tumors (12%) showed mutated patterns of p53 staining with intact SWI/SNF protein expression, and 1 tumor (3%) harbored a POLE exonuclease domain mutation (P286R). 28863077 2018
Entrez Id: 6935
Gene Symbol: ZEB1
ZEB1
0.010 AlteredExpression disease BEFREE Cytopathological and immunocytochemical findings of pancreatic anaplastic carcinoma with ZEB1 expression by means of touch imprint cytology. 28940869 2018
Entrez Id: 1045
Gene Symbol: CDX2
CDX2
0.010 Biomarker disease BEFREE As a result, one should not rely on CDX2 as evidence of intestinal differentiation or origin in metastatic undifferentiated carcinomas in the neck, particularly when staining is not strong and diffuse. 27389559 2018
Entrez Id: 84557
Gene Symbol: MAP1LC3A
MAP1LC3A
0.010 AlteredExpression disease BEFREE Tumoral LC3A and LC3B expressions were the highest in MC (<i>p</i> < 0.001), whereas stromal LC3A expression was higher in AC and PTC (<i>p</i> < 0.001). 28257096 2017
Entrez Id: 6595
Gene Symbol: SMARCA2
SMARCA2
0.010 Biomarker disease BEFREE Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. 27656868 2017
Entrez Id: 81631
Gene Symbol: MAP1LC3B
MAP1LC3B
0.010 AlteredExpression disease BEFREE Tumoral LC3A and LC3B expressions were the highest in MC (<i>p</i> < 0.001), whereas stromal LC3A expression was higher in AC and PTC (<i>p</i> < 0.001). 28257096 2017
Entrez Id: 54790
Gene Symbol: TET2
TET2
0.010 AlteredExpression disease BEFREE Alterations in the IDH2-wild-type sinonasal undifferentiated carcinomas included SMARCA4 loss-of-function with confirmed loss of immunohistochemical expression, NOTCH1 gain-of-function, and TET2 loss-of-function. 28084339 2017
Entrez Id: 664
Gene Symbol: BNIP3
BNIP3
0.010 AlteredExpression disease BEFREE BNIP-3 expression was absent in MC and AC (<i>p</i> = 0.013). 28257096 2017
Entrez Id: 110806263
Gene Symbol: LOC110806263
LOC110806263
0.010 GeneticVariation disease BEFREE TERT promoter mutations have been recently described (and associated with distant metastases and reduced survival) in papillary and follicular carcinomas, as well as in poorly differentiated and undifferentiated carcinoma. 26510840 2016
Entrez Id: 57016
Gene Symbol: AKR1B10
AKR1B10
0.010 AlteredExpression disease BEFREE In NPC tissues, AKR1B10 expression appeared high specifically in squamous cell carcinoma, but low in basal cell carcinoma, adenoid cystic carcinoma, adenocarcinoma and undifferentiated carcinoma (p= 0.000). 26835713 2016
Entrez Id: 3689
Gene Symbol: ITGB2
ITGB2
0.010 AlteredExpression disease BEFREE Despite a significant difference between Mac-1 expression in patients with and without cancer, a dramatic increase in Mac-1 expression was observed in the blood of patients with undifferentiated carcinomas compared with patients with other histological types of EOC. 26563750 2016
Entrez Id: 3684
Gene Symbol: ITGAM
ITGAM
0.010 AlteredExpression disease BEFREE Despite a significant difference between Mac-1 expression in patients with and without cancer, a dramatic increase in Mac-1 expression was observed in the blood of patients with undifferentiated carcinomas compared with patients with other histological types of EOC. 26563750 2016
Entrez Id: 5426
Gene Symbol: POLE
POLE
0.010 GeneticVariation disease BEFREE According to The Cancer Genome Atlas classification, we distributed 95% of the undifferentiated carcinomas in this series as follows: (a) hypermutated tumors with loss of any mismatch repair protein expression and microsatellite instability (eight cases, 45%); (b) ultramutated carcinomas carrying mutations in the exonuclease domain of POLE (two cases, 11%); (c) high copy number alterations (copy-number high) tumors group exhibiting only TP53 mutations and high number of alterations detected by FISH (two cases, 11%); and (d) low copy number alterations (copy-number low) tumors with molecular alterations typical of endometrioid endometrial carcinomas (five cases, 28%). 27491810 2016
Entrez Id: 406913
Gene Symbol: MIR126
MIR126
0.010 AlteredExpression disease BEFREE The expression of VEGF-A and miR-126 were measured in 101 thyroid carcinomas tissues (including 51 conventional papillary thyroid carcinoma, 37 follicular variant of papillary thyroid carcinoma, and 13 undifferentiated thyroid carcinomas), 13 matched lymph nodes with metastatic thyroid carcinoma, 21 benign thyroid tissues, and 5 thyroid carcinoma cell lines (both papillary and undifferentiated carcinomas). 27067785 2016
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.010 Biomarker disease BEFREE Of 18 PSCGCs with adenocarcinomatous or "undifferentiated" carcinoma differentiation, 8 were mutated for EGFR (n = 1), KRAS (n = 2), BRAF (n = 1), HER2 (n = 3), and PIK3CA (n = 1). 26826416 2016
Entrez Id: 4000
Gene Symbol: LMNA
LMNA
0.010 AlteredExpression disease BEFREE Follicular carcinomas (FCs) most frequently expressed lamin B, while none of the undifferentiated carcinomas (UCs) showed strong expression of emerin or lamin A/C. 26254781 2015
Entrez Id: 2010
Gene Symbol: EMD
EMD
0.010 AlteredExpression disease BEFREE Follicular carcinomas (FCs) most frequently expressed lamin B, while none of the undifferentiated carcinomas (UCs) showed strong expression of emerin or lamin A/C. 26254781 2015
Entrez Id: 6367
Gene Symbol: CCL22
CCL22
0.010 AlteredExpression disease BEFREE Women with endometrioid cystadenocarcinoma had higher PF CCL22 levels than women with undifferentiated carcinoma. 25647263 2015
Entrez Id: 55294
Gene Symbol: FBXW7
FBXW7
0.010 GeneticVariation disease BEFREE Sequencing analysis revealed that UCs harbored somatic mutations in PIK3CA (50%), CTNNB1 (30%), TP53 (30%), FBXW7 (20%), and PPP2R1A (20%). 24451280 2014
Entrez Id: 5518
Gene Symbol: PPP2R1A
PPP2R1A
0.010 GeneticVariation disease BEFREE Sequencing analysis revealed that UCs harbored somatic mutations in PIK3CA (50%), CTNNB1 (30%), TP53 (30%), FBXW7 (20%), and PPP2R1A (20%). 24451280 2014